Back
HFA Premium Access

Vascular stiffness, cardiac chamber stiffness and cardiovascular risk factors in women versus men with pre-HFpEF; a report from the PARABLE trial.

Session: Heart failure with preserved ejection fraction (HFpEF) 1
Topic: Heart Failure with Preserved Ejection Fraction (HFpEF)
Speaker: Doctor B. Wong (Dublin, IE)
Event: Heart Failure 2023

Congress Presentation

About the speaker

Doctor Bethany Wong

St Vincent's University Hospital, Dublin (Ireland)
2 presentations
1 follower

7 more presentations in this session

Safety and clinical effects of sodium-glucose cotransporter-2 inhibitors in transthyretin amyloid cardiomyopathy

Speaker: Doctor A. Nalbandian (New York, US)

Access
Abstract
Slides
Thumbnail

Impact of temporary LV systolic dysfunction on long-term clinical outcome in patients with preserved ejection fraction after acute myocardial infarction

Speaker: Doctor J. Kim (Seoul, KR)

Access
Abstract
Slides
Thumbnail

Left-to-right ventricular volume ratio and outcome in heart failure with preserved ejection fraction

Speaker: Doctor A. Aimo (Pisa, IT)

Access
Abstract
Slides
Thumbnail

Coronary microvascular dysfunction, central and overall obesity and metabolic and fibrotic biomarkers in patients with heart failure with preserved ejection fraction (data from PROMIS-HFpEF)

Speaker: Mr M. Erhardsson (Stockholm, SE)

Access
Abstract
Slides
Thumbnail

The prognostic value of hypoxemic burden measured by overnight oximetry in heart failure patients with preserved ejection fraction

Speaker: Miss S. Mourmans (Maastricht, NL)

Access
Abstract
Slides
Thumbnail

Access the full session

Heart failure with preserved ejection fraction (HFpEF) 1

Speakers: Doctor B. Wong, Doctor A. Nalbandian, Doctor J. Kim, Doctor A. Aimo, Mr M. Erhardsson...
Access
Thumbnail

About the event

Image

Heart Failure 2023

20 May - 23 May 2023

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb